Product Description: FR260330 is a selective, orally active inhibitor for inducible nitric oxide synthase (iNOS) through suppression of iNOS dimerization. FR260330 inhibits the NO accumulation in rat splenocytes and human DLD-110 cells, with IC50 of 27 and 10 nM. FR260330 ameliorates the Lipopolysaccharides (HY-D1056)-induced inflammatory diseases in rats model[1].
Applications: COVID-19-immunoregulation
Formula: C29H28ClF3N6O4
References: [1]Chida N, et al., Pharmacological profile of FR260330, a novel orally active inducible nitric oxide synthase inhibitor. Eur J Pharmacol. 2005 Feb 10;509(1):71-6.
CAS Number: 442198-67-6
Molecular Weight: 617.02
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: NO Synthase